67 related articles for article (PubMed ID: 35394149)
1. Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial.
Kaushal S; Hare JM; Hoffman JR; Boyd RM; Ramdas KN; Pietris N; Kutty S; Tweddell JS; Husain SA; Menon SC; Lambert LM; Danford DA; Kligerman SJ; Hibino N; Korutla L; Vallabhajosyula P; Campbell MJ; Khan A; Naioti E; Yousefi K; Mehranfard D; McClain-Moss L; Oliva AA; Davis ME
Eur Heart J Open; 2023 Mar; 3(2):oead002. PubMed ID: 36950450
[TBL] [Abstract][Full Text] [Related]
2. New Aspects in the Diagnosis and Therapy of Fetal Hypoplastic Left Heart Syndrome.
Graupner O; Enzensberger C; Axt-Fliedner R
Geburtshilfe Frauenheilkd; 2019 Aug; 79(8):863-872. PubMed ID: 31423021
[TBL] [Abstract][Full Text] [Related]
3. Cardiac tissue engineering for the treatment of hypoplastic left heart syndrome (HLHS).
Abraham R; Vricella L; Hibino N
Transl Pediatr; 2023 Aug; 12(8):1592-1600. PubMed ID: 37692536
[TBL] [Abstract][Full Text] [Related]
4.
Bejleri D; Robeson MJ; Brown ME; Hunter J; Maxwell JT; Streeter BW; Brazhkina O; Park HJ; Christman KL; Davis ME
Biomater Sci; 2022 Jan; 10(2):444-456. PubMed ID: 34878443
[TBL] [Abstract][Full Text] [Related]
5. Discussion to: Prospective randomized controlled trial of the safety and feasibility of a novel mesenchymal precursor cell therapy in hypoplastic left heart syndrome.
JTCVS Open; 2023 Dec; 16():673-674. PubMed ID: 38204676
[No Abstract] [Full Text] [Related]
6. Statistical modeling of extracellular vesicle cargo to predict clinical trial outcomes for hypoplastic left heart syndrome.
Hoffman JR; Park HJ; Bheri S; Platt MO; Hare JM; Kaushal S; Bettencourt JL; Lai D; Slesnick TC; Mahle WT; Davis ME
iScience; 2023 Oct; 26(10):107980. PubMed ID: 37868626
[TBL] [Abstract][Full Text] [Related]
7. Cell-based therapy to boost right ventricular function and cardiovascular performance in hypoplastic left heart syndrome: Current approaches and future directions.
Williams K; Khan A; Lee YS; Hare JM
Semin Perinatol; 2023 Apr; 47(3):151725. PubMed ID: 37031035
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cell-Based Modeling of Single-Ventricle Congenital Heart Diseases.
Parker LE; Kurzlechner LM; Landstrom AP
Curr Cardiol Rep; 2023 May; 25(5):295-305. PubMed ID: 36930454
[TBL] [Abstract][Full Text] [Related]
9. Narrative review of single ventricle: where are we after 40 years?
Corno AF; Findley TO; Salazar JD
Transl Pediatr; 2023 Feb; 12(2):221-244. PubMed ID: 36891374
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell RNA Sequencing Reveals Distinct Cardiac-Derived Stromal Cell Subpopulations.
Hoffman JR; Jayaraman AR; Bheri S; Davis ME
J Cardiovasc Dev Dis; 2022 Nov; 9(11):. PubMed ID: 36354773
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell therapy for hypoplastic left heart syndrome: Safety and feasibility of intraoperative intramyocardial injections.
Burkhart HM; Qureshi MY; Rossano JW; Cantero Peral S; O'Leary PW; Hathcock M; Kremers W; Nelson TJ;
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1614-1623. PubMed ID: 31345560
[TBL] [Abstract][Full Text] [Related]
13. Regenerative Medicine Strategies for Hypoplastic Left Heart Syndrome.
Chery J; Wong J; Huang S; Wang S; Si MS
Tissue Eng Part B Rev; 2016 Dec; 22(6):459-469. PubMed ID: 27245633
[TBL] [Abstract][Full Text] [Related]
14. The Miracle Baby Grows Up: Hypoplastic Left Heart Syndrome in the Adult.
Lewis M; Rosenbaum M
Curr Cardiol Rep; 2017 Aug; 19(8):74. PubMed ID: 28744764
[TBL] [Abstract][Full Text] [Related]
15. Autologous Cardiac Stem Cell Injection in Patients with Hypoplastic Left Heart Syndrome (CHILD Study).
Kaushal S; Hare JM; Shah AM; Pietris NP; Bettencourt JL; Piller LB; Khan A; Snyder A; Boyd RM; Abdullah M; Mishra R; Sharma S; Slesnick TC; Si MS; Chai PJ; Davis BR; Lai D; Davis ME; Mahle WT
Pediatr Cardiol; 2022 Oct; 43(7):1481-1493. PubMed ID: 35394149
[TBL] [Abstract][Full Text] [Related]
16. Study design and rationale for ELPIS: A phase I/IIb randomized pilot study of allogeneic human mesenchymal stem cell injection in patients with hypoplastic left heart syndrome.
Kaushal S; Wehman B; Pietris N; Naughton C; Bentzen SM; Bigham G; Mishra R; Sharma S; Vricella L; Everett AD; Deatrick KB; Huang S; Mehta H; Ravekes WA; Hibino N; Difede DL; Khan A; Hare JM
Am Heart J; 2017 Oct; 192():48-56. PubMed ID: 28938963
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
